CDNA
Overvalued by 106.3% based on the discounted cash flow analysis.
Market cap | $1.06 Billion |
---|---|
Enterprise Value | $971.41 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1 |
Beta | 2.18 |
Outstanding Shares | 55,262,459 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 17.88 |
---|---|
PEG | -47.23 |
Price to Sales | 3.17 |
Price to Book Ratio | 3.17 |
Enterprise Value to Revenue | 2.8 |
Enterprise Value to EBIT | 20.71 |
Enterprise Value to Net Income | 16 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data